DBVT (DBV Tech) Rasio Nilai Pasar marang Nilai Buku

Simbol resmi perusahaan dbv-technologies.com (DBVT)

The market price for DBV Technologies S.A. (DBVT) on GURU.Markets, which stands at 3.68 as confirmed by the chart, accompanies the operations of research centers in the US and France dedicated to creating unique transdermal systems. Current monetization is limited to the testing phase; therefore, future profits will depend on the terms set by US insurers. The business is based on the breakthrough Viaskin technology, aimed at combating severe forms of food allergies.

DBVT dbv-technologies.com: Nilai Pasar marang Nilai Buku ing interval 04.07.2022 - 27.10.2026

Rincian metrik keuangan lan pasar DBV Technologies S.A. (DBVT)

- rega lan prakiraan konsensus rega:
Kutipan saham dbv-technologies.com|DBVT - Rega prakiraan analis
- data kapitalisasi pasar:
Nilai pasar DBV Technologies SA|DBVT - Nilai Wutuh Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham DBV Technologies|DBVT - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku dbv-technologies.com|DBVT - Total Aset Perusahaan
- data utang lan likuiditas:
Utang marang Ekuitas DBV Technologies S.A.|DBVT - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas dbv-technologies.com|DBVT - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku DBV Technologies SA
Analisis wiwitan perusahaan:DBV Tech - DBVT
Produk asli dbv-technologies.com

The stability of DBV Technologies S.A. (DBVT) is based on strict adherence to biopharmaceutical standards during the development of anti-allergen patches. Analyzing this chart of the market capitalization to net asset ratio, an investor can see the gap between the exchange valuation and the actual value of assets, which allows for determining the degree of overpayment for the company relative to its actual book value.

Pesaing utama

KRYS - Rasio Kapitalisasi marang Aset Bersih|APGE (apogeetherapeutics.com) - Multiplikator Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Arcutis Biotherapeutics, Inc. ARQT|Kapitalisasi Pasar marang Aset Bersih Vericel Corp|Oruka Corp (ORKA) - Rasio Kapitalisasi Pasar marang Nilai Buku|Nilai Pasar marang Nilai Buku sanaramedtech.com (SMTI)|Rasio Kapitalisasi Pasar marang Nilai Buku SLSN (Solesence)|Journey Medical Corp - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Forte Biosciences (FBRX)|EMPG: Nilai Pasar marang Nilai Buku|SLGL (Sol-Gel) - Rasio Nilai Pasar marang Nilai Buku|AXIL Brands (AXIL) - Rasio Kapitalisasi marang Aset Bersih|MDCX (Medicus Pharma Ltd.) - Rasio Kapitalisasi Pasar marang Nilai Buku|Rasio Kapitalisasi Pasar marang Nilai Buku Verrica (VRCA)|Hoth Therapeutics, Inc. (HOTH) - Rasio Kapitalisasi marang Aset Bersih|Nilai Pasar marang Nilai Buku BFRI (biofrontera-us.com)|Rasio Nilai Pasar marang Nilai Buku VYNE|Sonoma Pharmaceuticals Inc. - Kapitalisasi Pasar marang Nilai Buku|Quoin Pharma - Rasio Nilai Pasar marang Nilai Buku|AZTR - Rasio Kapitalisasi Pasar marang Nilai Buku|Dermata Therapeutics, Inc. - Rasio Kapitalisasi Pasar marang Nilai Buku|ELAB (Elevai Labs Inc) - Kapitalisasi Pasar marang Nilai Buku|Rasio Nilai Pasar marang Nilai Buku Revance Therapeutics, Inc (RVNC)